Adiponectin has demonstratable an anti-fibrotic action in the liver and it was suggested that adiponectin may be developed as a new therapeutic candidate for the treatment of liver fibrosis (13). The gene discussed is ADIPOQ; the disease is Hepatic fibrosis.